2,6-dichloroindophenol has been researched along with A-Thalassemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaibunruang, A; Fucharoen, G; Fucharoen, S; Pornphannukool, S; Sae-Ung, N; Sanchaisuriya, K | 1 |
1 other study(ies) available for 2,6-dichloroindophenol and A-Thalassemia
Article | Year |
---|---|
Improvement of alpha(0)-thalassemia screening using combined osmotic fragility, dichlorophenolindophenol and Hb H inclusion tests.
Topics: 2,6-Dichloroindophenol; alpha-Thalassemia; Ascorbic Acid; Asia, Southeastern; Carrier State; Erythrocyte Count; Genotype; Hematocrit; Hemoglobin H; Hemoglobins; Humans; Mass Screening; Osmotic Fragility; Thailand | 2010 |